Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.
Isakova-Sivak I, Stukova M, Erofeeva M, Naykhin A, Donina S, Petukhova G, Kuznetsova V, Kiseleva I, Smolonogina T, Dubrovina I, Pisareva M, Nikiforova A, Power M, Flores J, Rudenko L. Isakova-Sivak I, et al. Among authors: smolonogina t. Hum Vaccin Immunother. 2015;11(4):970-82. doi: 10.1080/21645515.2015.1010859. Hum Vaccin Immunother. 2015. PMID: 25831405 Free PMC article. Clinical Trial.
Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections.
Korenkov D, Nguyen THO, Isakova-Sivak I, Smolonogina T, Brown LE, Kedzierska K, Rudenko L. Korenkov D, et al. Among authors: smolonogina t. Hum Vaccin Immunother. 2018 Apr 3;14(4):941-946. doi: 10.1080/21645515.2017.1417713. Epub 2018 Jan 23. Hum Vaccin Immunother. 2018. PMID: 29252117 Free PMC article.
Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Isakova-Sivak I, de Jonge J, Smolonogina T, Rekstin A, van Amerongen G, van Dijken H, Mouthaan J, Roholl P, Kuznetsova V, Doroshenko E, Tsvetnitsky V, Rudenko L. Isakova-Sivak I, et al. Among authors: smolonogina t. PLoS One. 2014 Jul 24;9(7):e102339. doi: 10.1371/journal.pone.0102339. eCollection 2014. PLoS One. 2014. PMID: 25058039 Free PMC article.
Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
Isakova-Sivak I, Korenkov D, Smolonogina T, Tretiak T, Donina S, Rekstin A, Naykhin A, Shcherbik S, Pearce N, Chen LM, Bousse T, Rudenko L. Isakova-Sivak I, et al. Among authors: smolonogina t. Virology. 2017 Jan;500:209-217. doi: 10.1016/j.virol.2016.10.027. Epub 2016 Nov 6. Virology. 2017. PMID: 27829176 Free PMC article.
Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
Korenkov DA, Laurie KL, Reading PC, Carolan LA, Chan KF, Isakova-Sivak II, Smolonogina TA, Subbarao K, Barr IG, Villanueva J, Shcherbik S, Bousse T, Rudenko LG. Korenkov DA, et al. Among authors: smolonogina ta. Infect Genet Evol. 2018 Oct;64:95-104. doi: 10.1016/j.meegid.2018.06.019. Epub 2018 Jun 19. Infect Genet Evol. 2018. PMID: 29929009 Free PMC article.
25 results